𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction

✍ Scribed by Leithead, J. A.; Hayes, P. C.; Ferguson, J. W.

Book ID
121687739
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
228 KB
Volume
39
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Racial disparities in the management of
Racial disparities in the management of hospitalized patients with cirrhosis and portal hypertension
✍ Robert P. Myers πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 2 views

HCC, we agree with Sangiovanni and Iavarone that similar ultrasound surveillance intervals appear to be adequate for both patient groups, as recommended by international guidelines. Still, clinicians should be aware of the potentially higher oncogenic risk of genotype 1b in addition to other recogni

Ascorbic acid improves the intrahepatic
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension
✍ Manuel HernΓ‘ndez-Guerra; Juan C. GarcΓ­a-PagΓ‘n; Juan Turnes; Pablo Bellot; RamΓ³n πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 239 KB πŸ‘ 1 views

Patients with cirrhosis show intrahepatic endothelial dysfunction, characterized by an impaired flow-dependent vasorelaxation. This alteration is responsible for the marked postprandial increase in portal pressure and is attributed to an insufficient release of nitric oxide (NO). Ascorbic acid rever